Crossref
Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib
Clinical Medicine Reviews in Oncology · 2010
DOI: 10.4137/cmro.s3276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Verfasst von Susanne Rogers and Imogen Locke.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Locke, S. R. A. I. (2010). Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s3276
Vancouver
Locke SRAI. Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s3276
BibTeX
@article{Locke2010,
author = {Locke, Susanne Rogers and Imogen},
title = {Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib},
journal = {Clinical Medicine Reviews in Oncology},
year = {2010},
doi = {10.4137/cmro.s3276}
}
EUVIMED